Please assess the completion status of the following clinical trial:

Trial Title: rhPTH Therapy for Low Turnover Bone Fragility

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* :patients with history of increased bone fragility by BMD criteria (T score \> -1). In addition, the subjects will be enrolled only if they have clear evidence of low bone turnover as indicated by low normal levels of biochemical markers of bone turnover and finding of low bone turnover on bone biopsy. Each subject and his/her treating physician will have agreed that the rhPTH is the best treatment for the patient. Treatment with rhPTH will be considered only if the bone histomorphometry reveals a low turnover state and excludes other known forms of bone disease such as osteomalacia.~Exclusion Criteria:~* Subjects who are pregnant or younger than 20 will be excluded. Subjects cannot have osteoporosis

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- rhPTH (Type: EXPERIMENTAL): Subjects will be treated rhPTH for 12 months

Based on this trial design, predict the completion outcome and termination type (if applicable).